MINNELIDE, A PROMISING COMPOUND FOR THE TREATMENT OF HIGH-RISK MEDULLOBLASTOMA

被引：0
|
作者：
Blanco, Jezabel Rodriguez [1 ]
Salvador, April [1 ]
Sahani, Pritika [1 ]
Kliebe, Valentin [1 ]
Peterson, Kendell [1 ]
Turos, Maria [1 ]
机构：
[1] Med Univ South Carolina, Charleston, SC USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae064.555
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MDB-107
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir
    Gringmuth, Marieke
    Walther, Jenny
    Greiser, Sebastian
    Toussaint, Magali
    Schwalm, Benjamin
    Kool, Marcel
    Kortmann, Rolf-Dieter
    Glasow, Annegret
    Patties, Ina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [42] Personalizing the Treatment of Pediatric Medulloblastoma: Polo-like Kinase 1 as a Molecular Target in High-Risk Children
    Triscott, Joanna
    Lee, Cathy
    Foster, Colleen
    Manoranjan, Branavan
    Pambid, Mary Rose
    Berns, Rachel
    Fotovati, Abbas
    Venugopal, Chitra
    O'Halloran, Katrina
    Narendran, Aru
    Hawkins, Cynthia
    Ramaswamy, Vijay
    Bouffet, Eric
    Taylor, Michael D.
    Singhal, Ash
    Hukin, Juliette
    Rassekh, Rod
    Yip, Stephen
    Northcott, Paul
    Singh, Sheila K.
    Dunham, Christopher
    Dunn, Sandra E.
    CANCER RESEARCH, 2013, 73 (22) : 6734 - 6744
  • [43] PERSONALIZING THE TREATMENT OF PEDIATRIC MEDULLOBLASTOMA: POLO-LIKE KINASE 1 AS A MOLECULAR TARGET IN HIGH-RISK CHILDREN
    Sheila, Cathy
    Lee, Singh
    Foster, Colleen
    Manoranjan, Branavan
    Pambit, Mary
    Berns, Rachel
    Fotovati, Abbas
    Venugopal, Chitra
    O'Halloran, Katherine
    Narendran, Arul
    Hawkins, Cynthia
    Ramaswamy, Vijay
    Bouffet, Eric
    Taylor, Michael
    Singhal, Ash
    Hukin, Juilette
    Rassekh, Rod
    Yip, Stephen
    Northcott, Paul
    Singh, Sheila
    Duhman, Chris
    Dunn, Sandra
    NEURO-ONCOLOGY, 2014, 16 : 77 - 77
  • [44] Relapsed High-Risk Medulloblastoma: Stable Disease after Two Years of Treatment with Somatostatin Analog - Case Report
    Galvis, Luisa
    Gonzalez, Diego
    Bonilla, Carlos
    CUREUS, 2016, 8 (01):
  • [45] Novel Immunotherapy Promising Against High-Risk Prostate Cancers
    不详
    US PHARMACIST, 2023, 48 (06) : 31 - 33
  • [46] THE ROLE OF ARHGAP36 AS A NOVEL DRIVER IN HIGH-RISK HUMAN MEDULLOBLASTOMA
    Jackson, Pauline J.
    Larson, Jon D.
    Beckmann, Dominic A.
    Moriarity, Branden S.
    Largaespada, David A.
    NEURO-ONCOLOGY, 2013, 15 : 19 - 19
  • [47] High-Risk Medulloblastoma: Does c-myc Amplification Overrule Histopathology?
    Raabe, Eric H.
    Eberhart, Charles G.
    PEDIATRIC BLOOD & CANCER, 2010, 54 (03) : 344 - 345
  • [48] Proton versus photon craniospinal irradiation in Pediatric patients with high-risk medulloblastoma
    Lassaletta, A.
    Panizo, E.
    Vazquez, F.
    Serrano, F. J.
    Carceller, E.
    Gonzalez-San Segundo, C.
    Aristu, J.
    Calvo, F.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S875 - S876
  • [49] Treatment of high-risk myelodysplastic syndromes
    Fenaux, Pierre
    HEMATOLOGIE, 2006, 12 : 12 - 13
  • [50] TREATMENT OF HIGH-RISK HYPERTENSION IN 1989
    PLOIN, M
    GAZETTE MEDICALE, 1989, 96 (25): : 59 - 59
12345